Page last updated: 2024-11-02

pd 98059 and Pituitary Neoplasms

pd 98059 has been researched along with Pituitary Neoplasms in 8 studies

2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one: inhibits MAP kinase kinase (MEK) activity, p42 MAPK and p44 MAPK; structure in first source
2-(2-amino-3-methoxyphenyl)chromen-4-one : A member of the class of monomethoxyflavones that is 3'-methoxyflavone bearing an additional amino substituent at position 2'.

Pituitary Neoplasms: Neoplasms which arise from or metastasize to the PITUITARY GLAND. The majority of pituitary neoplasms are adenomas, which are divided into non-secreting and secreting forms. Hormone producing forms are further classified by the type of hormone they secrete. Pituitary adenomas may also be characterized by their staining properties (see ADENOMA, BASOPHIL; ADENOMA, ACIDOPHIL; and ADENOMA, CHROMOPHOBE). Pituitary tumors may compress adjacent structures, including the HYPOTHALAMUS, several CRANIAL NERVES, and the OPTIC CHIASM. Chiasmal compression may result in bitemporal HEMIANOPSIA.

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's4 (50.00)18.2507
2000's3 (37.50)29.6817
2010's1 (12.50)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Horiguchi, K1
Yamada, M1
Satoh, T1
Hashimoto, K1
Hirato, J1
Tosaka, M1
Yamada, S1
Mori, M1
Petiti, JP1
GutiƩrrez, S1
De Paul, AL1
Andreoli, V1
Palmeri, CM1
Sosa, Ldel V1
Bocco, JL1
Torres, AI1
Niiori-Onishi, A1
Iwasaki, Y1
Mutsuga, N1
Oiso, Y1
Inoue, K1
Saito, H1
Li, H1
Robinson, PJ1
Kawashima, S1
Funder, JW1
Liu, JP1
Kanasaki, H1
Fukunaga, K1
Takahashi, K1
Miyazaki, K1
Miyamoto, E1
Wang, YH1
Maurer, RA2
Kievit, P1
Lauten, JD1
Manfroid, I1
Martial, JA1
Muller, M1

Other Studies

8 other studies available for pd 98059 and Pituitary Neoplasms

ArticleYear
Transcriptional activation of the mixed lineage leukemia-p27Kip1 pathway by a somatostatin analogue.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2009, Apr-15, Volume: 15, Issue:8

    Topics: Adult; Androstadienes; Antineoplastic Agents, Hormonal; Base Sequence; Cell Line, Tumor; Cyclin-Depe

2009
GH3B6 pituitary tumor cell proliferation is mediated by PKCalpha and PKCepsilon via ERK 1/2-dependent pathway.
    Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology, 2010, Volume: 26, Issue:2

    Topics: Animals; Bromodeoxyuridine; Cell Proliferation; Flavonoids; Flow Cytometry; Mitogen-Activated Protei

2010
Molecular mechanisms of the negative effect of insulin-like growth factor-I on growth hormone gene expression in MtT/S somatotroph cells.
    Endocrinology, 1999, Volume: 140, Issue:1

    Topics: Androstadienes; Animals; Dose-Response Relationship, Drug; Enzyme Inhibitors; Flavonoids; Gene Expre

1999
Differential regulation of MAP kinase activity by corticotropin-releasing hormone in normal and neoplastic corticotropes.
    The international journal of biochemistry & cell biology, 1998, Volume: 30, Issue:12

    Topics: 8-Bromo Cyclic Adenosine Monophosphate; Animals; Atrial Natriuretic Factor; Calcium-Calmodulin-Depen

1998
Mitogen-activated protein kinase activation by stimulation with thyrotropin-releasing hormone in rat pituitary GH3 cells.
    Biology of reproduction, 1999, Volume: 61, Issue:1

    Topics: Androstadienes; Animals; Benzylamines; Calcium; Calcium-Calmodulin-Dependent Protein Kinases; Cyclic

1999
A role for the mitogen-activated protein kinase in mediating the ability of thyrotropin-releasing hormone to stimulate the prolactin promoter.
    Molecular endocrinology (Baltimore, Md.), 1999, Volume: 13, Issue:7

    Topics: Animals; Binding Sites; Calcium; Calcium-Calmodulin-Dependent Protein Kinases; DNA-Binding Proteins;

1999
Analysis of the role of the mitogen-activated protein kinase in mediating cyclic-adenosine 3',5'-monophosphate effects on prolactin promoter activity.
    Molecular endocrinology (Baltimore, Md.), 2001, Volume: 15, Issue:4

    Topics: Animals; Binding Sites; Colforsin; CREB-Binding Protein; Cyclic AMP; Cyclic AMP-Dependent Protein Ki

2001
Inhibition of protein phosphatase PP1 in GH3B6, but not in GH3 cells, activates the MEK/ERK/c-fos pathway and the human prolactin promoter, involving the coactivator CPB/p300.
    Molecular endocrinology (Baltimore, Md.), 2001, Volume: 15, Issue:4

    Topics: Animals; DNA-Binding Proteins; E1A-Associated p300 Protein; Enzyme Inhibitors; Flavonoids; Humans; I

2001